Status:
RECRUITING
Botulinum Toxin Injection in the Treatment of Open Abdomen
Lead Sponsor:
University of Oulu
Conditions:
Open Abdomen
Botulinum Toxin Injection
Eligibility:
All Genders
18+ years
Brief Summary
Botulinum toxin has been widely approved and utilized in the treatment of complex abdominal wall hernias. Botulinum toxin has been only randomly studied in the treatment of open abdomen.
Detailed Description
30 consecutive patients who have open abdomen for any indication, will have 300 IU botulinum toxin injected in three spots in either sides of the abdomen within 72 hours of the start of open abdomen. ...
Eligibility Criteria
Inclusion
- Open abdomen
Exclusion
- Previous incisional hernia in midline
- Patient is not in active treatment
Key Trial Info
Start Date :
February 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04283916
Start Date
February 21 2020
End Date
August 1 2024
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oulu University Hospital
Oulu, Finland